LINC01116 was previously uncovered to be upregulated and act as an oncogene in several cancers, including osteosarcoma,11 prostate cancer.12 Consistent with these findings, we proved in this study that LINC01116 was highly expressed in NPC cells and its suppression hindered NPC cell proliferation and migration. The gene discussed is LINC01116; the disease is prostate cancer.